Document Detail

Comparison of intravenous oxytocin and prostaglandin E2 for accelerating labour.
MedLine Citation:
PMID:  1268536     Owner:  NLM     Status:  MEDLINE    
In a prospective study of 52 consecutive women who required acceleration of labour intravenous prostaglandin E2 (PGE2) was used as the oxytocic agent. These mothers were matched for age, parity, height, gestational age, initial cervical dilatation, and station and position of the fetal head with 52 women whose labours were accelerated with oxytocin; both drugs were equally effective. Acceleration to delivery intervals, second-stage durations, the number of assisted deliveries, and Apgar scores were similar regardless of the oxytocic used. Although PGE2 compares well with oxytocin, it offers no further advantages and is more expensive and less well tried than oxytocin.
A R Weekes; H H Makanji; C R West
Related Documents :
20626366 - Preterm elective caesarean section and early enteral feeding in gastroschisis.
31586 - Neonatal acid-base balance in spontaneous and instrumental vaginal deliveries.
18366486 - Current caesarean delivery rates and indications in a major public hospital in northern...
2786846 - Gardnerella vaginalis vaginitis in cu t 200 users.
22605296 - Meningitis in the child with a smile-reply.
24732876 - Altered innate immune development in hiv-exposed uninfected infants.
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  British medical journal     Volume:  1     ISSN:  0007-1447     ISO Abbreviation:  Br Med J     Publication Date:  1976 Apr 
Date Detail:
Created Date:  1976-08-02     Completed Date:  1976-08-02     Revised Date:  2010-09-07    
Medline Journal Info:
Nlm Unique ID:  0372673     Medline TA:  Br Med J     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  987-8     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Apgar Score
Infant, Newborn
Labor Stage, Second / drug effects
Labor, Induced / methods*
Labor, Obstetric / drug effects
Oxytocin / pharmacology,  therapeutic use*
Prospective Studies
Prostaglandins E / pharmacology,  therapeutic use*
Time Factors
Reg. No./Substance:
0/Prostaglandins E; 50-56-6/Oxytocin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Influence of maternal obesity on subcutaneous fat in the newborn.
Next Document:  Plasma nicotine levels after cigarette smoking and chewing nicotine gum.